trending Market Intelligence /marketintelligence/en/news-insights/trending/O1X_tDzSNSg51tLka0dQBg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

US FDA approves Teva Pharmaceutical's pain medication

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


US FDA approves Teva Pharmaceutical's pain medication

The U.S. FDA approved Teva Pharmaceutical Industries Ltd.'s Vantrela for pain.

The treatment is formulated with Teva's proprietary abuse-deterrent technology.